You are viewing the site in preview mode

Skip to main content

Table 1 Clinicopathological characteristics of HCC patients

From: An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy

 

Low (N = 51)

High (N = 26)

p-value

Sex

   

 female

10 (19.6%)

4 (15.4%)

0.887

 male

41 (80.4%)

22 (84.6%)

 

Age (Years)

   

 Mean (SD)

58.4 (12.4)

56.8 (10.6)

0.581

HBV.DNA

   

 < 1000 IU/mL

32 (62.7%)

17 (65.4%)

0.820

 > 1000 IU/mL

19 (37.3%)

9 (34.6%)

 

AFP

   

 < 400 ng/mL

31 (60.8%)

16 (61.5%)

0.949

 > 400 ng/mL

20 (39.2%)

10 (38.5%)

 

TBIL (µmol/L)

   

 Median [Min, Max]

14.2 [6.50, 141]

17.0 [8.50, 47.5]

0.200

ALB (g/L)

   

 Mean (SD)

39.1 (4.69)

38.7 (4.28)

0.733

PT (s)

   

 Median [Min, Max]

11.8 [1.10, 24.9]

12.4 [10.8, 16.1]

0.054

Operation. time (minutes)

   

 Median [Min, Max]

212 [93.0, 582]

224 [89.0, 392]

0.742

Blood. loss

   

 ≤ 300 mL

40 (78.4%)

20 (76.9%)

0.880

 > 300 mL

11 (21.6%)

6 (23.1%)

 

Hepatectomy

   

 ≤ 2 segmentectomy

40 (78.4%)

23 (88.5%)

0.443

 > 2 segmentectomy

11 (21.6%)

3 (11.5%)

 

Tumor. diameter

   

 < 5 cm

25 (49.0%)

12 (46.2%)

0.812

 > 5 cm

26 (51.0%)

14 (53.8%)

 

Satellite. nodules

   

 No

37 (72.5%)

22 (84.6%)

0.237

 Yes

14 (27.5%)

4 (15.4%)

 

MVI

   

 No

25 (49.0%)

15 (57.7%)

0.471

 Yes

26 (51.0%)

11 (42.3%)

 

Differentiation

   

 Medium-high

25 (49.0%)

17 (65.4%)

0.173

 Low

26 (51.0%)

9 (34.6%)

 
  1. Abbreviations: HCC, Hepatocellular carcinoma; AFP, alpha-fetoprotein; PT, prothrombin time; ALB, albumin; TBIL, total bilirubin; MVI, microvascular invasion